The treatment of Bursitis & Leukoplakia with vitamins

Bursitis and Leukoplakia: Mitamins custom make quality formulas for the treatment of Bursitis & Leukoplakia with vitamins. A Bursitis & Leukoplakia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Bursitis and Leukoplakia

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    800
    mg
    1333%
    Vitamin E
    100
    IU
    333%
    Lycopene
    500
    mcg
    *
    Grape Seed Extract
    100
    mg
    *
  • Amount Per Serving
    % DV
    Green Tea Extract
    50
    mg
    *
    Turmeric Extract
    300
    mg
    *
    Bromelain
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Bursitis and Leukoplakia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Rabies Vaccine Development At UGA Receives NIH Grant
The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has awarded the University of Georgia College of Veterinary Medicine a $1.18 million grant to develop rabies virus vaccines. This award is the continuation of a previous four-year $837,000 grant issued by NIAID in 2002 to initiate the study.
CODEX Paving The Way For Safety Assessment Of Products With GM Low Level Presence
European industry representatives welcome the decision taken by the Codex ad hoc Task Force on Foods Derived from Biotechnology to advance a proposal addressing the risk assessment of low-level presence of biotech plant materials, found in food or feed, which have been authorised in one or more countries but not yet in the importing country. The decision follows negotiations by members of the Codex ad hoc Task Force meeting this week in Chiba, Japan.
This information concerning the support of Bursitis and Leukoplakia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments